INFLIXIMAB, INFLIXIMAB
EPIC Study
Approved small_molecule active
Quick answer
INFLIXIMAB, INFLIXIMAB for Inflammatory Bowel Disease is a Approved program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Istituto Gentili S.r.l.
- Indication
- Inflammatory Bowel Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active